Related references
Note: Only part of the references are listed.An update on beta-lactamase inhibitor discovery and development
Jean-Denis Docquier et al.
DRUG RESISTANCE UPDATES (2018)
Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Validation of Scores and Proposal for Management
Angela Cano et al.
CLINICAL INFECTIOUS DISEASES (2018)
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections
Massimo Sartelli et al.
WORLD JOURNAL OF EMERGENCY SURGERY (2017)
Global antimicrobial resistance in Gram-negative pathogens and clinical need
Ursula Theuretzbacher
CURRENT OPINION IN MICROBIOLOGY (2017)
In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
John E. Mazuski et al.
CLINICAL INFECTIOUS DISEASES (2016)
B1-Metallo-beta-Lactamases: Where Do We Stand?
Maria F. Mojica et al.
CURRENT DRUG TARGETS (2016)
In Vitro Activity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013
Douglas J. Biedenbach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam
Renu Singh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control
T. Tangden et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Early Liver Dysfunction in Patients With Intra-Abdominal Infections
Kun Guo et al.
MEDICINE (2015)
Antibiotic management of complicated intra-abdominal infections in adults: The Asian perspective
Asok Kurup et al.
ANNALS OF MEDICINE AND SURGERY (2014)
Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers
Jared L. Crandon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Ready for a world without antibiotics? The Pensieres Antibiotic Resistance Call to Action
Jean Carlet et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2012)
Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing Enterobacteriaceae
David M. Livermore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria
Yen-Hsu Chen et al.
JOURNAL OF INFECTION (2011)
Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
Timothy R. Walsh et al.
LANCET INFECTIOUS DISEASES (2011)
Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-induced Liver Injury in the United States
Naga Chalasani et al.
GASTROENTEROLOGY (2008)
In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide:: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)
Flavia Rossi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy
EJC Goldstein et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Share Paper
